Economic Times
Novo Nordisk is relaunching a diabetes tablet as Ozempic in the United States. This move aims to boost sales by using the strong brand recognition of its popular Ozempic drug. The new Ozempic pills will be available in specific doses for adults starting Monday. Novo Nordisk seeks to regain market share from competitor Eli Lilly.
Go to News Site